NCT06626347Completed
Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support
Application of the Telemedicine for Reach, Education, Access, and Treatment Delivery Model to Engage Emerging Adults in Diabetes Self-Management Education and Support
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
Emerging adults with type 1 diabetes are a vulnerable population. While diabetes self-management and education is known to offer opportunities to develop self-management skills required to achieve and maintain short- and long-term diabetes outcomes, emerging adults are reported to have poor clinic attendance and in turn low participation in diabetes self-management education and support services. This pilot study aims to test a novel approach to diabetes self-management education and support that incorporates technological and applied learning-driven methods delivered through group telemedicine visits to improve emerging adults engagement in diabetes self-management education and support with the ultimate goal of improving diabetes outcomes.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 49 (actual)
- First submitted
- 1 Oct 2024
- Start date
- 8 Nov 2024
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- University of Pittsburgh
- Diseases
- Type 1 diabetes
- NCT number
- NCT06626347
What you commit to
- Study type: Interventional
- Participants enrolled: 49
- From 8 Nov 2024 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Do not have a diagnosis of type 1 diabetes (ICD10 E10.xx, O24.0x)
Age
- Less than 18 or older than 26 years old at time of enrollment
Other
- Do not intend to maintain their care at participating clinical sites throughout the duration of the study
- Are unable to communicate via telemedicine
- Has other concerns that may interfere significantly with their ability to participate in the intervention (ongoing health issues, personal events, etc.)
Who the study is looking for
- Diagnosed with type 1 diabetes (ICD10 E10.xx, O24.0x)
- 18 to 26 years of age at time of study enrollment
- Able to communicate via videoconferencing platform
- Intending to maintain status as a patient at participating clinical sites throughout the study duration
- Able to provide informed consent
Age in the registry: 18 years to 26 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UPMC Childrens Hospital of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.